ArticleMilitary Medical Research2025
National mortality burden attributable to the unprecedented heatwave in 2022 in China.
Article in Military Medical Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Protecting High-Vulnerability Elderly in Climate Emergencies: Lessons from Beijing's 2025 Floods.Environment & health (Washington, D.C.) · 2026Article
- Evaluation of Photoprotective Strategies in AsexualPlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2022, China experienced an unprecedented heatwave event, raising concerns about the health impacts of heatwaves. This study aims to understand the devastating health risk of the exceptional heatwave in 2022 by comparing heatwave-related mortality burden in 2022 with that during 2000-2021.
methodsWe collected daily mortality and daily maximum temperature (DMT) during 2006-2017 in 364 locations (counties/districts) of China. Heatwave was defined as an event with 2 or more consecutive days of DMT exceeding the 92.5th percentile. We employed a distributed lag nonlinear model (DLNM) and a meta-analysis to examine the heatwave-mortality association based on the data from 364 counties/districts, and then this association was used to assess the mortality burden attributable to heatwaves during 2000-2022 in 368 cities in China. A percentage change (%) indicator, comparing the 2022 mortality burden to the average value from 2000 to 2021, was further calculated to highlight the severity of heatwaves in 2022.
resultsIn the past 2 decades, the frequency and intensity of heatwaves in China significantly increased, with the cumulative excessive degree-day increasing to 31,626 in 2022 compared with the annual average value of 13,772 during 2000-2021 across China. In 2022, we observed 62,961 [95% confidence internal (CI) 54,945-70,413] heatwave-related deaths in China, which was much higher than the annual average [35,987 (95% CI 31,252-40,471)] attributable to heatwaves during 2000-2021. The vulnerability groups of heatwave-related mortality in 2022 primarily included patients with cardiovascular diseases [40,567 (95% CI 35,313-45,404)], females [35,876 (95% CI 31,035-41,005)], and people aged over 65 years [56,208 (95% CI 49,023-62,864)]; and greater heatwave-related mortality was found in eastern-central China. The attributable fraction (AF) of heatwave-related deaths increased from an annual average of 11.01‰ (95% CI 9.56-12.38) during 2000-2021 to 18.11‰ (95% CI 15.80-20.25) in 2022 with 64.43% increment (95% CI 38.10-93.78), and the increase rates were greater in Xizang Autonomous Region (159.77%, 95% CI 12.84-477.87) and Sichuan Province (133.64%, 95% CI 3.84-416.61).
conclusionsThis study indicated that the frequency and intensity of heatwaves significantly increased in the past 2 decades in China, and the 2022 heatwaves were linked to a substantial mortality burden in China, with significant population and regional heterogeneity. Our findings underscore the need for developing comprehensive heat adaptation plans in the context of rapid aging and ongoing global warming.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.